ARMISTICE CAPITAL, LLC - 31 Mar 2025 SCHEDULE 13G Report for Calidi Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (CLDI)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Calidi Biotherapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: CLDI
Shares outstanding: 33,630,240 shares
Disclosed Ownership: 3,359,661 shares
Ownership: 9.99%
Form type: SCHEDULE 13G
Filing time: 15 May 2025, 15:14:34 UTC
Date of event: 31 Mar 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	9.99%	3,359,661	0	3,359,661	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	9.99%	3,359,661	0	3,359,661	/s/ Steven Boyd	Steven Boyd